198 results on '"Rowe, C C."'
Search Results
2. Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer’s Disease using Cerebrospinal Fluid Biomarkers in the AIBL Study
3. Imaging of tau deposits in adults with Niemann-Pick type C disease: a case-control study
4. Two-year prognostic utility of plasma p217+tau across the Alzheimer’s continuum
5. A[Beta] Deposits in Older Non-Demented Individuals with Cognitive Decline Are Indicative of Preclinical Alzheimer's Disease
6. Tau imaging with [18F]THK‐5351 in progressive supranuclear palsy
7. Cross-Sectional and Longitudinal Comparison of Tau Imaging with 18F-MK6240 and 18F-Flortaucipir in Populations Matched for Age, MMSE and Brain Beta-Amyloid Burden.
8. Prognostic serum miRNA biomarkers associated with Alzheimer’s disease shows concordance with neuropsychological and neuroimaging assessment
9. Dietary patterns and cognitive decline in an Australian study of ageing
10. A blood-based predictor for neocortical Aβ burden in Alzheimer’s disease: results from the AIBL study
11. Associations between gonadotropins, testosterone and β amyloid in men at risk of Alzheimer’s disease
12. Cerebrovascular disease, Alzheimerʼs disease biomarkers and longitudinal cognitive decline: OR2
13. APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimerʼs disease
14. Physical activity and amyloid-β plasma and brain levels: results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing
15. HIGHER AB BURDEN IN HEALTHY APOE-E4 CARRIERS IS ASSOCIATED WITH SUBJECTIVE MEMORY COMPLAINTS: RESULTS FROM THE FLUTEMETAMOL AND PIB AIBL COHORTS: O40
16. DETECTION OF PRODROMAL ALZHEIMERʼS DISEASE WITH 18F-FLORBETABEN IMAGING: A PROSPECTIVE OUTCOME STUDY: O37
17. THE USE OF 99MTC-DISIDA FOR ASSESSMENT OF FUTURE REMNANT LIVER: O24
18. VQ SPECT/CT VS. CTPA – THE IMPACT OF CHANGES OF BREAST TISSUE WEIGHTING FACTOR ON RADIATION EXPOSURE AND CANCER RISK: O16
19. Galantamine-induced improvements in cognitive function are not related to alterations in α4β2 nicotinic receptors in early Alzheimer’s disease as measured in vivo by 2-[18F]Fluoro-A-85380 PET
20. MilxXplore: a web-based system to explore large imaging datasets
21. IMAGING AND COGNITIVE BIOMARKERS AS PREDICTORS OF PROGRESSION TO ALZHEIMERʼS DISEASE: O38
22. A TWO-YEAR LONGITUDINAL ASSESSMENT OF Aβ DEPOSITION IN MCI WITH 18F-FLORBETABEN: O35
23. WHEN IS A HIGH BLOOD GLUCOSE LEVEL TOO HIGH FOR FDG-PET BRAIN IMAGING FOR DEMENTIA?: O18
24. Correlating the frontal presentation of Alzheimerʼs disease with frontal metabolism as measured by FDG-PET: S14 Session 14: Oral Presentations 3 May 2012 1400-1415 Oral Presentation 32
25. 11C-PiB PET studies in typical sporadic Creutzfeldt–Jakob disease
26. Amyloid load in Parkinson’s disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography
27. Memory Profiling With Paired Associate Learning in Alzheimerʼs Disease, Mild Cognitive Impairment, and Healthy Aging
28. Relationship between nicotinic receptors and cognitive function in early Alzheimerʼs disease: A 2-[18F]fluoro-A-85380 PET study
29. CEREBRAL AMYLOID ANGIOPATHY PREDISPOSES TO TPA RELATED HAEMORRHAGE IN PATIENTS PRESENTING WITH ACUTE ISCHAEMIC STROKE: A PIB PET STUDY: 1
30. IN VIVO DETECTION OF CEREBRAL AMYLOID DEPOSITION USING 11C PIB PET IN PATIENTS WITH CEREBRAL AMYLOID ANGIOPATHY HAEMORRHAGE: 2
31. Aβ deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimerʼs disease
32. DETECTION OF CEREBRAL AMYLOID DEPOSITION USING [11C]PIB PET IN PATIENTS WITH PROBABLE CEREBRAL AMYLOID ANGIOPATHY
33. Three probiotic strains exert different effects on plasma bile acid profiles in healthy obese adults: randomised, double-blind placebo-controlled crossover study.
34. 0297 An Association Between Amyloid Burden and Cognition in Severe Obstructive Sleep Apnea
35. Intracerebral Haemorrhage: Incidence And Use Of Computed Tomography
36. PET-only 18F-AV1451 tau quantification
37. Imaging of tau deposits in adults with Niemann-Pick type C disease: a case-control study.
38. Tau imaging with [18F]THK‐5351 in progressive supranuclear palsy
39. Relationships Between Performance on the Cogstate Brief Battery, Neurodegeneration, and A Accumulation in Cognitively Normal Older Adults and Adults with MCI
40. Tau imaging with [18F] THK-5351 in progressive supranuclear palsy.
41. APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer’s disease
42. Manifold drived MR-less PiB SUVR normalisation
43. Impaired default network functional connectivity in autosomal dominant Alzheimer disease
44. Three-Month Stability of the CogState Brief Battery in Healthy Older Adults, Mild Cognitive Impairment, and Alzheimer's Disease: Results from the Australian Imaging, Biomarkers, and Lifestyle-Rate of Change Substudy (AIBL-ROCS)
45. Bifidobacterium bifidum R0071 decreases stress-associated diarrhoea-related symptoms and self-reported stress: a secondary analysis of a randomised trial.
46. 18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease
47. 11C-PIB binding is increased in patients with cerebral amyloid angiopathy-related hemorrhage
48. β-Amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia
49. Galantamine-induced improvements in cognitive function are not related to alterations in α4β2 nicotinic receptors in early Alzheimer’s disease as measured in vivo by 2-[18F]Fluoro-A-85380 PET
50. IMAGING -AMYLOID BURDEN IN AGING AND DEMENTIA
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.